ADIPOPHARMA
Live / Allowed — Approved for publication (as of 27 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 01 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79425256
- Mark type
- Design + words
- Filed
- 01 Apr 2025
- Attorney of record
- Pina Campagna
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; medications for human medicine for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; chemical preparations for medical use for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; chemical preparations for pharmaceutical use for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; diagnostic preparations for medical use; cultures of microorganisms for medical use; stem cells for medical use; sanitary preparations for medical purposes; foodstuffs and dietetic food and beverages adapted for medical or veterinary use
- Class 042 — Scientific and technological services: Scientific and technological services, namely, research and design relating to drugs, pharmaceuticals, medicine; research and development services in the field of pharmacy and in particular medicines; research and development of new products for third parties; biological research; bacteriological research; chemical research; cosmetic science research; technical research in the field of new product development; scientific laboratory services; chemical analysis; material testing; technical project studies namely, conducting of feasibility studies in the field of new technologies; surveying being engineering services, engineering
Owner
- AdipoPharma, FR
Prosecution history
- 27 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Nov 2025 — REFUSAL PROCESSED BY IB
- 28 Oct 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 28 Oct 2025 — REFUSAL PROCESSED BY MPU
- 11 Sept 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 10 Sept 2025 — NON-FINAL ACTION WRITTEN
- 28 Aug 2025 — ASSIGNED TO EXAMINER
- 06 Jun 2025 — APPLICATION FILING RECEIPT MAILED
- 06 Jun 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 05 Jun 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB